Clinical Trials on Refractory Transformed Non-Hodgkin Lymphoma
Total 5686 results
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma of Soft TissueChina
-
Sohag UniversityNot yet recruiting
-
Centre Hospitalier Universitaire DijonRecruitingNon-hodgkin's LymphomaFrance
-
Xynomic Pharmaceuticals, Inc.Cancer Institute and Hospital, Chinese Academy of Medical SciencesActive, not recruitingNon Hodgkin LymphomaChina
-
MorphoSys AGCompletedNon-Hodgkin LymphomaUnited States, Belgium, Germany, Hungary, Italy, Poland, Spain
-
Gilead SciencesTerminated
-
Assiut UniversityCompleted
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
University of BelgradeUnknownNon-hodgkin LymphomaSerbia
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First Affiliated Hospital of Zhengzhou UniversityUnknown
-
Nordic NanovectorWithdrawnNon-Hodgkin LymphomaGermany
-
Samsung Medical CenterMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin LymphomaKorea, Republic of
-
Beijing Immunochina Medical Science & Technology...Peking University Cancer Hospital & InstituteUnknownNon Hodgkin LymphomaChina
-
Centre Leon BerardAmgenTerminated
-
Radboud University Medical CenterUnknown
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Asociacion Espanola de Hematologia y HemoterapiaCompleted
-
Instituto Nacional de Cancerologia de MexicoUnknownNon-Hodgkin LymphomaMexico
-
Chiron CorporationTerminatedNon-Hodgkin LymphomaUnited States
-
WiSP Wissenschaftlicher Service Pharma GmbHLudwig-Maximilians - University of Munich; Chugai Pharma GmbHCompletedHodgkin's Disease | Non-Hodgkin Lymphomas | Multiple Myelomas
-
Immune DesignMerck Sharp & Dohme LLCTerminatedFollicular Low Grade Non-Hodgkin's Lymphoma
-
British Columbia Cancer AgencyHoffmann-La RocheActive, not recruitingLymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaCanada
-
Bristol-Myers SquibbCompletedCancer - Solid Tumors and B-Cell Non-Hodgkin's LymphomaUnited States, France, Spain, Germany
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | B-cell Non-Hodgkin's LymphomaUnited States
-
PfizerCompletedHodgkin Disease | Thrombocytopenia | Non-Hodgkin LymphomaUnited States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
-
University Hospital, BrestTeva Pharmaceuticals USATerminatedCerebral Lymphoma B Cell RefractoryFrance
-
University of PittsburghBiogenCompletedNon-Hodgkin LymphomaUnited States
-
Cellectis S.A.RecruitingB-cell Non-Hodgkin Lymphoma (B-NHL)United States, Spain, France
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
University of CologneNovartisTerminated
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States
-
Grupo Argentino de Tratamiento de la Leucemia AgudaTakedaRecruitingRefractory Hodgkin Lymphoma | Hodgkin Lymphoma, Adult | Relapsed Hodgkin's Disease, AdultArgentina
-
Sheba Medical CenterCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Autologous Stem Cell Transplantation | Stem Cell MobilizationIsrael
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
GlyPharma TherapeuticsVectivBio AGWithdrawnLymphoma, Non-Hodgkin's, Adult | Lymphoma, Hodgkin's, Adult
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Australia
-
PrECOG, LLC.Genentech, Inc.CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma Follicular | Non-Hodgkin's Lymphoma, Adult High GradeUnited States
-
Genentech, Inc.Completed
-
National Cancer Institute (NCI)Enrolling by invitationAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Non-Hodgkins Lymphoma | Myelodysplastic Syndrome (MDS) | Hodgkins LymphomaUnited States
-
Czech Lymphoma Study GroupRecruitingNon Hodgkin Lymphoma (NHL)Czechia
-
Juventas Cell Therapy Ltd.CompletedDiffuse Non-Hodgkin LymphomaChina
-
Gruppo Italiano Studio LinfomiUnknown
-
Affiliated Hospital of Nantong UniversityNot yet recruiting
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
Innate PharmaRecruitingNon Hodgkin LymphomaUnited States, Australia
-
Cho Pharma Inc.RecruitingNon-Hodgkin LymphomaTaiwan, United States